Oncology Clinical Trials in Grand Rapids, MI

As of July 2026, 172 paid clinical trials are recruiting for Oncology in Grand Rapids, Michigan. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

175 clinical trials for Oncology

·Clear filters·↓ Download CSV

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for Locally Advanced Solid Tumor

Sites in Grand Rapids +5 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213817·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

for Advanced Solid Tumor

Sites in Grand Rapids +5 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213830·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

for Colorectal Cancer

1 location in Grand Rapids

Sponsor: GE Healthcare

Sex: All·Age: 18+

Code: NCT07219238·Phase 2, Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

for Breast Cancer

Drug: Giredestrant

Sites in Grand Rapids +1 more location

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT07214662·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

for Lymphoma

Sites in Grand Rapids +6 more locations

Sponsor: Treeline Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07082803·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Study of ZW251 in Participants With Advanced Solid Tumors

for Hepatocellular Carcinoma

Sites in Grand Rapids +7 more locations

Sponsor: Zymeworks BC Inc.

Sex: All·Age: 18+

Code: NCT07164313·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Pumitamig

Sites in Grand Rapids +3 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07079631·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

for Colorectal Neoplasms

Sites in Grand Rapids +4 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06663319·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

for Ovarian Neoplasms

Sites in Grand Rapids +8 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06400472·Phase 1·Recruiting·Listed May 2024

Apply to this trial

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

for Castration-Resistant Prostate Cancer (CRPC)

Sites in Grand Rapids +3 more locations

Sponsor: Radiopharm Theranostics, Ltd

Sex: All·Age: 18+

Code: NCT07189871·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

for Advanced Solid Tumor

Sites in Grand Rapids +4 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT06833008·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study of JNJ-87890387 for Advanced Solid Tumors

for Neoplasms

Sites in Grand Rapids +1 more location

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06178614·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

for Urothelial Carcinoma Bladder

Sites in Grand Rapids +11 more locations

Sponsor: Aktis Oncology, Inc.

Sex: All·Age: 18+

Code: NCT07020117·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for NSCLC (Advanced Non-small Cell Lung Cancer)

Sites in Grand Rapids, Farmington Hills +6 more locations

Sponsor: ALX Oncology Inc.

Sex: All·Age: 18+

Code: NCT07085091·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)

for Gastroesophageal Junction

Sites in Grand Rapids +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06445972·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of MGC028 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Grand Rapids +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06723236·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for Advanced Solid Tumors

Drug: Calderasib

Sites in Grand Rapids +4 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05067283·Phase 1·Recruiting·Listed Oct 2021

Apply to this trial

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

for Leukemia, Acute Myeloid

Sites in Grand Rapids +5 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT05362773·Phase 1·Recruiting·Listed May 2022

Apply to this trial

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for Mesothelin-Expressing Tumors

Sites in Grand Rapids +8 more locations

Sponsor: Context Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06756035·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for Platinum-resistant Ovarian Cancer

Sites in Grand Rapids +6 more locations

Sponsor: MacroGenics

Sex: Female·Age: 18+

Code: NCT06730347·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

for Gastroesophageal Junction

Sites in Grand Rapids +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06469944·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Grand Rapids +3 more locations

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05985655·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for Prostate Cancer Castration-resistant Prostate Cancer

Sites in Grand Rapids +6 more locations

Sponsor: MBrace Therapeutics

Sex: All·Age: 18+

Code: NCT07145255·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Sites in Grand Rapids +6 more locations

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT06969430·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Grand Rapids +6 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06804824·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

ARC101 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +2 more locations

Sponsor: Third Arc Bio

Sex: All·Age: 18+

Code: NCT06672185·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

Study of AUBE00 in Patients With Solid Tumors

for Solid Tumors

Sites in Grand Rapids +1 more location

Sponsor: Chugai Pharmaceutical

Sex: All·Age: 18+

Code: NCT07030959·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study of YL242 in Subjects With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +6 more locations

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT07197827·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +6 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06750185·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

A Study of MGC026 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Grand Rapids +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06242470·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Grand Rapids +3 more locations

Sponsor: Tanabe Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT06943521·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

for Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)

Sites in Grand Rapids +6 more locations

Sponsor: Olema Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06784193·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for Solid Tumors

Sites in Grand Rapids +7 more locations

Sponsor: Adcentrx Therapeutics

Sex: All·Age: 18+

Code: NCT06710379·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

for Metastatic Sarcoma

Sites in Grand Rapids +4 more locations

Sponsor: Lantheus Medical Imaging

Sex: All·Age: 15+

Code: NCT06298916·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors

for Solid Tumor

Sites in Grand Rapids +3 more locations

Sponsor: Qualigen Theraputics, Inc.

Sex: All·Age: 18+

Code: NCT06086522·Phase 1·Recruiting·Listed Oct 2023

Apply to this trial

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

for Breast Cancer

Sites in Grand Rapids, Wyoming +1103 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 18 - 60

Code: NCT05879926·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

for Acute Lymphoblastic Leukemia

Sites in Grand Rapids, Wyoming +629 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 40 - 75·Accepts healthy volunteers

Code: NCT05334069·Recruiting·Listed Apr 2022

Apply to this trial

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

for Head and Neck Squamous Cell Carcinoma

Sites in Grand Rapids, Wyoming +464 more locations

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All·Age: 18+

Code: NCT02734537·Phase 2·Recruiting·Listed Apr 2016

Apply to this trial

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for Chronic Lymphocytic Leukemia

Sites in Grand Rapids, Wyoming +306 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04269902·Phase 3·Recruiting·Listed Feb 2020

Apply to this trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

for Lung Non-Small Cell Carcinoma

Sites in Grand Rapids, Wyoming +638 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04267848·Phase 3·Recruiting·Listed Feb 2020

Apply to this trial

Conditions in Oncology (Grand Rapids, MI)

Solid tumor· 44 Non-small cell lung cancer (NSCLC)· 29 Colorectal cancer· 26 Breast cancer· 19 Pancreatic cancer· 14 Ovarian cancer· 12 Cancer (any)· 11 Gastric cancer· 10 Bladder cancer· 9 Endometrial cancer· 9 Triple-negative breast cancer· 8 Melanoma· 8 Prostate cancer· 7 Non-Hodgkin lymphoma· 7 Esophageal cancer· 6 Biliary tract cancer· 6 Multiple myeloma· 6 Acute myeloid leukemia (AML)· 6 Diffuse large B-cell lymphoma (DLBCL)· 6 Hematologic malignancy· 6 Head and neck cancer· 6 Metastatic breast cancer· 5 Gastroesophageal junction cancer· 5 Cervical cancer· 5 Metastatic prostate cancer· 4 Kidney cancer· 4 Chronic lymphocytic leukemia (CLL)· 4 Neuroblastoma· 4 Liver cancer· 3 Leukemia (other)· 3 Myelodysplastic syndromes (MDS)· 3 Small lymphocytic lymphoma· 3 Sarcoma· 3 Ewing sarcoma· 3 Metastatic colorectal cancer· 2 Acute lymphoblastic leukemia· 2 Hodgkin lymphoma· 2 Neuroendocrine tumors· 2 HER2-positive breast cancer· 1 Lung cancer· 1 Colon cancer· 1 Rectal cancer· 1 Gastrointestinal cancer· 1 Uterine cancer· 1 Fallopian tube cancer· 1 Brain metastases· 1 Chronic myelomonocytic leukemia· 1 Myeloproliferative neoplasm· 1 Mantle cell lymphoma· 1 Burkitt lymphoma· 1 Thyroid cancer· 1 Soft tissue sarcoma· 1 Osteosarcoma· 1 Mesothelioma· 1